Endocrine System: ADH, Thyroid, and Adrenal Glands Study Guide

ADH / Vasopressin

  • Function and Location:
    • Stimulates the reabsorption of water in the distal and collecting tubules of the kidney.
    • Also affects the salivary glands and the small intestine.
    • Its primary action results in a decrease of diuresis (urine production).
  • Mechanism of Action:
    • Opens specific water channels known as aquaporins.
    • The movement of water through these channels is passive, driven by the osmotic gradient.
  • Physiological Impact:
    • Regulates approximately 1015%10-15\% of the water reabsorbed in the kidneys.
    • This accounts for a volume of roughly 1718dm3/24h17-18\,dm^3/24\,h.
  • Vascular Effect:
    • Acts as a vasopressor, constricting the blood vessels (hence the name vasopressin).
  • Regulation of Secretion:
    1. Osmolality: Release is stimulated by an increase in blood osmolality (e.g., after consuming salty fish). Osmotic receptors located in the hypothalamus are positioned near the ADH-producing cells.
    2. Volume Receptors: Secretion is triggered following a 1015%10-15\% decrease in blood volume.
    3. Alcohol: Known to decrease ADH secretion, leading to increased diuresis.
    4. Nicotine: Acts as a stimulant for ADH secretion.
  • Pathology:
    • ADH Insufficiency (Diabetes Insipidus): Characterized by excessive diuresis, with urine output reaching 1820dm3/24h18-20\,dm^3/24\,h.

Thyroid Gland: Anatomy and Hormones

  • Microscopic Structure:
    • Follicles: Lined with cuboidal epithelium.
    • Colloid: Stored within the follicles; contains thyroglobulin, the precursor for thyroid hormones.
    • Parafollicular Cells: Also known as C-cells, located between the follicles.
  • Hormone Types:
    • The gland releases two iodine-containing follicular hormones synthesized from iodine and the amino acid tyrosine:
      • Thyroxine (Tetraiodothyronine) - T4T_4
      • Triiodothyronine - T3T_3
    • It also releases one non-iodine-containing hormone from the parafollicular cells:
      • Calcitonin: Essential for calcium (CaCa) and phosphorus (PP) homeostasis.

Physiological Effects of Thyroid Hormones (T3T_3 and T4T_4)

  • Metabolic Effects:
    • Increases tissue oxygen (O2O_2) consumption.
    • Calorigenic Effect: Increases heat production and the Basal Metabolic Rate (BMR).
    • Protein Metabolism:
      • Within normal physiological ranges, these hormones have an anabolic effect.
      • Levels higher than normal result in a catabolic effect.
  • Growth and Development:
    • Essential for the development and normal functioning of the Central Nervous System (CNS); deficiency can lead to mood changes or cretinism.
    • Critical for normal physical growth; it is considered the most important hormone for body and mental development during the first year of a child's life.
  • Systemic Effects:
    • Carbohydrate Metabolism: Exhibits a hyperglycemic effect.
    • Lipid Metabolism: Exhibits a lipolytic effect.
    • Cardiovascular: Increases the sensitivity of the heart to catecholamines, which can lead to a condition known as cor thyreotoxicum.
    • Muscular: Affects the velocity of muscle contraction.
    • Digestive: Regulates the motor functions of the Gastrointestinal Tract (GIT).

Regulation and Diseases of the Thyroid

  • Regulation of Secretion:
    • Hypothalamus: Releases TRH (Thyrotropin-Releasing Hormone) stimulated by birth, stress, or temperature changes.
    • Pituitary Gland: TRH stimulates the pituitary to release TSH (Thyroid-Stimulating Hormone).
    • Thyroid Gland: TSH stimulates the production of T4T_4 and T3T_3.
    • Negative Feedback Loop: High levels of thyroid hormones suppress the release of TRH and TSH; low levels stimulate them.
    • Peripheral Tissues: Much of T4T_4 is converted to the more active T3T_3 in the periphery.
  • Clinical Disorders:
    • Hypothyroidism (Decreased Production):
      • In children: Leads to nanism (dwarfism) accompanied by cretinism.
      • In adults: Results in myxedema.
    • Hyperthyroidism (Increased Production):
      • Conditions include Thyrotoxicosis and Grave disease.
      • Goiter: An enlargement of the thyroid gland, which can be endemic.

Adrenal Gland Structure and Medulla

  • Adrenal Cortex Zones:
    • Zona Glomerulosa: Produces mineralocorticoids.
    • Zona Fasciculata: Produces glucocorticoids and sex hormones.
    • Zona Reticularis: Produces glucocorticoids and sex hormones.
  • Adrenal Medulla:
    • Described as a modified sympathetic ganglion.
    • Functions as part of the sympathetic-adrenal system, innervated by preganglionic sympathetic neurons.
    • Termed "liquid sympathicus" due to its hormonal release into the blood.
    • Secretions:
      • Epinephrine (Adrenalin): 80%80\%
      • Norepinephrine (Noradrenalin): 20%20\%
      • Also secretes Enkephalins and Endorphins.
    • Role: Mediates the stress response via adrenoceptors.

Glucocorticoids (GC)

  • Primary Hormones: Cortisol and Corticosterone.
  • Metabolism: Degraded in the liver into cortisone.
  • Metabolic and Vascular Effects:
    • Hyperglycemic Effect: Increases gluconeogenesis from amino acids.
    • Catabolic and Lipolytic Effects: Breaks down proteins and fats.
    • Vascular Sensitivity: Increases the sensitivity of blood vessels to catecholamines.
  • Digestive and Blood Effects:
    • Digestive: Stimulates secretion of digestive juices but decreases mucosal defense mechanisms, leading to an ulcer effect.
    • Blood Changes:
      • Decreased Eosinophils (EoEo) and lymphocytes.
      • Decrease in lymph node size/activity.
      • Increase in Red Blood Cell (RBC) count.
      • Increase in hemocoagulation (blood clotting).
  • Immune and Bone Effects:
    • Suppresses immune reactions (primary reason for use in treating allergies).
    • Suppresses bone formation; prolonged therapy can lead to osteoporosis or decreased height in children.

Clinical Application and Regulation of Glucocorticoids

  • Therapeutic Uses:
    • Anti-inflammatory and anti-proliferative effects.
    • Immunosuppressive effects for allergic and autoimmune conditions.
  • Clinical Cautions (The "Why" of Dose-schemas):
    • Risk of Osteoporosis.
    • Risk of Steroid Diabetes.
    • Risk of Ulcers.
    • Risk of Hypertension.
  • Regulation of Secretion:
    • Hypothalamus: Releases CRF (Corticotropin-Releasing Factor), stimulated by stress and circadian rhythms.
    • Pituitary: CRF stimulates the release of ACTH (Adrenocorticotropic Hormone).
    • Adrenal Cortex: ACTH stimulates the cortex to release Cortisol.
    • Negative Feedback: Cortisol inhibits both the hypothalamus and pituitary.
  • Diurnal Rhythm:
    • Cortisol levels oscillate throughout the day, with a significant secretory surge approximately one hour after awakening in the morning.
  • Pathology:
    • Cushing Disease (Hyperadrenocorticism):
      • Symptoms include facies lunata ("moon face") and fat pads on the back of the neck ("buffalo hump").
      • Associated with hypertension, steroid diabetes, and osteoporosis.